Skip to main content
Michael Farkouh, MD, Cardiology, Los Angeles, CA

Michael Farkouh MD


Vice Dean, Research and Clinical Trials Cedars-Sinai Health System Professor, Cardiology Smidt Heart Institute Los Angeles, CA

Join to view full profile
  • 127 S San Vicente BlvdSte 3600Los Angeles, CA 90048

  • Phone+1 310-423-2726

  • Fax+1 310-423-6795

Dr. Farkouh is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • BronxCare Health System
    BronxCare Health SystemResidency, Gastroenterology, 2020 - 2026
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 1996 - 1998
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1989 - 1992
  • University of Western Ontario
    University of Western OntarioClass of 1988

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2009 - 2028
  • CA State Medical License
    CA State Medical License 2025 - 2027
  • MN State Medical License
    MN State Medical License 1989 - 1996

Awards, Honors, & Recognition

  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Moving Beyond the Stent  
    Michael Farkouh, MD, JACC: Cardiovascular Imaging

Lectures

  • Prevention of Heart Failure with SGLT-2 Inhibition Insights from CVD-REAL 
    56th Annual Scientific Session & Expo, New Orleans, Louisiana, USA

Authored Content

  • Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary InterventionAugust 2020
  • Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary InterventionAugust 2020
  • Prevention of Heart Failure with SGLT-2 Inhibition Insights from CVD-REALMay 2018

Press Mentions

  • BlackDoctor.org: 4 Health Experts Address Clinical Trials Myths and Assumptions
    BlackDoctor.org: 4 Health Experts Address Clinical Trials Myths and AssumptionsJune 18th, 2025
  • CTSNet Webinar: Unifying Revascularization Guidelines Across Continents and Specialties
    CTSNet Webinar: Unifying Revascularization Guidelines Across Continents and SpecialtiesJanuary 22nd, 2025
  • Cedars-Sinai Taps Renowned Cardiologist as Associate Dean of Clinical Trials
    Cedars-Sinai Taps Renowned Cardiologist as Associate Dean of Clinical TrialsJanuary 19th, 2023

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: